Wells Fargo sees improvement in a key metric
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
TL;DR
- Wells Fargo's net interest margin (NIM) for the current quarter is flat to one basis point down from Q2, exceeding prior guidance of a 3-4 basis point decline.
- This improvement is notable as Wells Fargo's NIM has missed estimates in nine of the last ten quarters.
- Berenberg upgraded Eli Lilly to 'buy', emphasizing the market's underestimation of benefits from recent acquisitions funded by its obesity drug success.
- Analysts highlight that new pipeline entrants from Lilly's acquisitions have multibillion-dollar sales potential and offer diversification.
- Eli Lilly has committed approximately $60 billion to over 25 business development deals so far in 2026, including acquisitions and license deals.
- The Federal Reserve's upcoming meeting will include the release of an updated Summary of Economic Projections (SEP), featuring the 'dot plot' indicating officials' rate expectations.
- The article mentions Jim Cramer's Charitable Trust and the CNBC Investing Club's trading alert procedures.